The PI3K/AKT/mTOR signaling pathway, for instance, has been shown to participate in the cell pro-survival and metabolic reprogramming involving fatty acid metabolism, glycolysis, and tricarboxylic acid cycle in B-cell lymphoma [250]. The gene discussed is AKT1; the disease is B-cell non-Hodgkin lymphoma.